Sinovac Biotech Ltd (NASDAQ:SVA)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$462.7M

Company Description

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Contact Information

Sinovac Biotech Ltd.
Zhongguancun Science & Technology
Beijing Beijing 102200
P:861056931800
Investor Relations:
861082799871

Employees

Shareholders

Mutual fund holders0.00%
Other institutional0.00%
Individual stakeholders--

Top Executives

Wei Dong YinChairman, President, CEO, Secretary & MD
Qiang GaoChief Operating Officer & Vice President
Nan WangCFO & Vice President-Business Development
Ming XiaVice President
Xiao Mei YinVice President-Sales & Marketing